Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

December 1, 2014
Telesta Therapeutics Announces Key Clinical & Corporate Updates

November 25, 2014
BIONICHE LIFE SCIENCES INC. REBRANDS AS TELESTA THERAPEUTICS INC.

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Archived Releases

November 2003

04/11/03
Bioniche Reports First Quarter Fiscal 2004 Results

October 2003

21/10/03
Nebraska Research Studies Confirm Efficacy of E. coli Vaccine

September 2003

15/09/03
Bioniche Reports 2003 Year-End Results

09/09/03
Bioniche Completes Second Tranche of $13.5 Million Financing

August 2003

15/08/03
Preliminary Results of North American Cystistat® Trial Announced

July 2003

14/07/03
Bioniche Pharma Group Receives FDA Approval For Cardiovascular Sterile Injectable

June 2003

17/06/03
Two Research Studies on Canadian E. coli Vaccine Presented at VTEC International Symposium in Edinburgh

06/06/03
Bioniche Announces Private Financing Completion

03/06/03
Bioniche Ranked Among Canada’s Top 100 Fastest Growing Companies

03/06/03
Bioniche Ranked Among Canada’s Top 100 Fastest Growing Companies

02/06/03
Results of Independent European Study on Cystistat®

May 2003

26/05/03
Bioniche Life Sciences Inc. Completes $13.5 Million Financing

23/05/03
Third Quarter Results

22/05/03
Bioniche Reaches Agreement with Fidia Farmaceutici S.p.A.

April 2003

30/04/03
Urology Platform Presented at American Urology Association Annual Meeting

March 2003

18/03/03
Bioniche Life Sciences Announces Additional Bladder Cancer Results

February 2003

17/02/03
Bioniche Posts 40% Consolidated Revenue Increase

January 2003

08/01/03
Bioniche Pharma Receives FDA Approval For Promethazine 10ml

December 2002

13/12/02
Bioniche Receives FDA Approval For Urology Product

October 2002

31/10/02
Bioniche Announces Webcast of Fiscal 2003 First Quarter Results Conference Call

30/10/02
Bioniche Life Sciences Announces First Quarter 2003 Results

30/10/02
Bioniche Launches Amiodarone I.V. Vials in the U.S. with Baxter

17/10/02
Bioniche Receives FDA Approval For Sterile Injectable

September 2002

30/09/02
Bioniche Presents Positive anti-cancer data in leukemia and lymphoma

24/09/02
Bioniche Makes Four Presentations At Prestigious SIU Congress

05/09/02
Bioniche Life Sciences Reports 2002 Year-End Results

03/09/02
Bioniche Defends Patent Infringement Litigation

July 2002

23/07/02
Bioniche Receives FDA Tentative Approval For Sterile Injectable

17/07/02
Bioniche Receives FDA Approval for EDTA Injection

08/07/02
“Bioniche Animal Health” New Name for Vetrepharm

03/07/02
Bioniche Appoints Martin J. Warmelink New President for Global Animal Health Business

June 2002

14/06/02
Bioniche Hires Dr. Marc Rivière as Senior Vice President and Chief Medical Officer

13/06/02
Bioniche Life Sciences Appoints New Member to its Board

10/06/02
Bioniche Presents Positive Study Findings on Breast Cancer

May 2002

27/05/02
Bioniche Reports Positive 12-Month Results From Bladder Cancer Trial

24/05/02
Bioniche Life Sciences Inc. Receives Ontario Global Traders Award

08/05/02
Bioniche Life Sciences Announces Third Quarter 2002 Results

01/05/02
Bioniche Announces Webcast of Third Quarter 2002 Conference Call

April 2002

19/04/02
Bioniche Subsidiary Receives C$1.8 Million Investment

February 2002

26/02/02
Bioniche Life Sciences signs agreement with US pharmaceutical company

20/02/02
Bioniche Life Sciences Signs Agreement at Team Canada Trade Mission

19/02/02
Bioniche Life Sciences Receives U.S. FDA Approval For Sterile Injectable

06/02/02
Bioniche Life Sciences Reports Strong Second Quarter and First Half 2002 Results

05/02/02
Bioniche Life Sciences Receives U.S. Patent for Company's Lead Technology

04/02/02
Bioniche Life Sciences Strengthens Its Intellectual Property Portfolio With Key U.S. Patent

January 2002

31/01/02
Bioniche Life Sciences Receives Key European Patent For MCC

December 2001

18/12/01
Bioniche Life Sciences Inc. Receives $1.4 Million Funding From Government of Ontario

13/12/01
Bioniche Life Sciences Inc. and Chiesi Sign Suplasyn Distribution Agreement for France

November 2001

01/11/01
Bioniche Life Sciences Inc. Funds $4 Million Research Chair in Food Safety

01/11/01
Bioniche Life Sciences Inc. Acquires Production Facility in Montreal

October 2001

30/10/01
Bioniche Life Sciences Inc. Reports Strong First Quarter Results

05/10/01
Bioniche Life Sciences Inc. Makes Acquisition in Animal Health Sector

05/10/01
Bioniche Life Sciences Inc. Makes Acquisition in Animal Health Sector

September 2001

24/09/01
Bioniche Life Sciences Inc. Announces 2001 Year-End Financial Results

24/09/01
Bioniche Life Sciences Inc. Announces 2001 Year-End Financial Results

July 2001

24/07/01
Bioniche Life Sciences Inc. and Technology Partnerships Canada Hold Ceremony to mark $17.2 Million Investment

24/07/01
Bioniche Life Sciences Inc. and Technology Partnerships Canada Hold Ceremony to mark $17.2 Million Investment

04/07/01
Bioniche Life Sciences Inc. Completes $10 Million Financing

04/07/01
Bioniche Life Sciences Inc. Completes $10 Million Financing

June 2001

28/06/01
Bioniche Life Sciences Inc. Completes First Tranche of $10 Million Financing

25/06/01
Bioniche Reports Phase I/II Bladder Cancer Trial Results

25/06/01
Bioniche Reports Phase I/II Bladder Cancer Trial Results

May 2001

28/05/01
Bioniche Life Sciences Inc. Announces 2001 Third Quarter Financial Results

28/05/01
Bioniche Life Sciences Inc. Announces 2001 Third Quarter Financial Results

28/05/01
Bioniche Life Sciences Inc. Announces 2001 Third Quarter Financial Results

April 2001

19/04/01
Bioniche Life Sciences Marks Progress in Global Expansion

19/04/01
Bioniche Life Sciences Marks Progress in Global Expansion

March 2001

13/03/01
Bioniche Life Sciences Completes Major European Distribution Network with New Partner

13/03/01
Bioniche Life Sciences Completes Major European Distribution Network with New Partner

07/03/01
Bioniche Life Sciences Enters North American Urology Collaboration

February 2001

22/02/01
Bioniche Life Sciences Inc. Announces Second Quarter 2001 Financial Results

January 2001

17/01/01
Bioniche Announces Approval to Begin Phase I Study of MCC as Treatment for Prostate Cancer

December 2000

19/12/00
Bioniche Reports Interim Bladder Cancer Trial Results - An encouraging 57% positive response rate demonstrated -

05/12/00
Bioniche Recognized as one of Canada’s Top-Ten Emerging Biotech Companies

November 2000

28/11/00
Bioniche Life Sciences Inc. Announces 2001 First Quarter Financial Results

16/11/00
Bioniche Life Sciences Provides Preclinical Scientific Update

October 2000

30/10/00
Bioniche Life Sciences Announces New Distribution Agreements for Suplasyn

September 2000

28/09/00
Bioniche Life Sciences' Cystistat® Gets Marketing Boost in Germany

20/09/00
New E.coli vaccine to be produced in Canada

19/09/00
Bioniche Life Sciences Inc. Announces Year-end Results

13/09/00
Bioniche Presents Important New Anti-Cancer Findings at the Hyaluronan 2000 International Meeting

07/09/00
Bioniche Receives Approval for Expanded Indications in Europe for Cystistat®

August 2000

31/08/00
Bioniche Presents Leukemia Study Findings at 28th World Congress of The International Society Of Hematology

14/08/00
Bioniche’s MCC Shows Broad Activity Against Prostate Cancer in Preclinical Testing

June 2000

28/06/00
Bioniche Life Sciences Inc. announces Italian distribution agreement for Cystistat®

07/06/00
Bioniche Life Sciences Inc. Discovers New Class of Molecules with Potent Anti-Cancer Activity

05/06/00
Bioniche Life Sciences Inc.'s Animal Health Subsidiary Divests Autogenous Bacterin Division - Divestiture Allows Vetrepharm to Focus on Major Pipeline Products

May 2000

10/05/00
Marketing opportunities expand for Bioniche Life Sciences' Cystistat® - Company Receives Approval for Expanded Indications in Canada

February 2000

02/02/00
Bioniche Life Sciences Inc. announces completion of $13 million financing

January 2000

27/01/00
Bioniche Life Sciences Inc. announces licensing agreement with Merckle for German market

10/01/00
Bioniche Life Sciences Inc. announces financing in pharma division

November 1999

29/11/99
Bioniche Life Sciences Inc. announces first quarter results

15/11/99
Bioniche Life Sciences Inc. Announces Year-End Results for Bioniche Inc.

August 1999

19/08/99
Bioniche Announces IND Approval


Newsroom

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Human Health
One Health

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy